RxFinder.ai

Acetohydroxamic Acid

Lithostat

Urease Inhibitor

NADAC/unit $6.6784
No Shortage Tier 1: 0.3% PA Req: 0.3%
vs. brand Lithostat: Generic saves up to 33% per unit

Generic Manufacturers

MISSION PHARMACAL CO

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.